Knockdown of ZEB1 in two highly aggressive pancreatic cancer cell lines resulted in a reduction of tumorigenicity in limiting dilution assays as well as reduced tumor dissemination in an orthotopic nude mouse model. This evidence concerns the gene ZEB1 and familial pancreatic carcinoma.